US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Sales | 61 | 18 | 46 | 360 | 57 |
| Cost of Goods | 1 | 1 | 20 | 205 | 11 |
| Gross Profit | 60 | 17 | 27 | 155 | 46 |
| Operating Expenses | 2,596 | 2,683 | 3,312 | 2,133 | 11,907 |
| Operating Income | -2,535 | -2,666 | -3,266 | -1,773 | -11,850 |
| Interest Expense | 1,620 | 2,013 | 2,139 | 2,663 | 2,401 |
| Other Income | 138 | -18 | 246 | 0 | 46 |
| Pre-tax Income | -4,017 | -4,697 | -5,160 | -4,436 | -14,205 |
| Net Income Continuous | -4,017 | -4,697 | -5,160 | -4,436 | -14,205 |
| Net Income | $-4,017 | $-4,697 | $-5,160 | $-4,436 | $-14,205 |
| EPS Basic Total Ops | -30.00 | -80.00 | -190.00 | -250.00 | -970.00 |
| EPS Basic Continuous Ops | -27.42 | -82.27 | -189.91 | -251.36 | -973.41 |
| EPS Diluted Total Ops | -30.00 | -80.00 | -190.00 | -250.00 | -970.00 |
| EPS Diluted Continuous Ops | -27.42 | -82.27 | -189.91 | -251.36 | -973.41 |
| EBITDA(a) | $-1,956 | $-1,463 | $-2,161 | $-409 | $-10,462 |